A multi-center, open-label, long-term, follow-up study of the safety and efficacy of levetiracetam [Keppra] (Ucb L059) in children with epilepsy.
Phase of Trial: Phase III
Latest Information Update: 17 Feb 2017
At a glance
- Drugs Levetiracetam (Primary)
- Indications Partial epilepsies
- Focus Therapeutic Use
- Sponsors UCB
- 13 Jul 2007 Status changed from in progress to completed.
- 17 Jul 2006 New trial record.